P
ProHub
English 简体中文 繁體中文
McKinsey Medium Market Entry Growth Strategy Operational Efficiency

Lasio virus

#Healthcare #Public Health #Vaccination
ProHub Comment

This is a structured brainstorming and quantitative case combining creative problem-solving (Q3) with mathematical analysis (Q4). The case teaches candidates to develop multi-dimensional solutions addressing awareness, access, experience, and incentives while also stress-testing assumptions through calculation and contextualization.

Estimated Time 15 minutes
Difficulty Medium
Source PeterK
50 / 100
Not explicitly labeled in provided pages - Case concerns increasing Lasio virus vaccination rates in a country, with two main questions: Q3 asks for suggestions to increase vaccinated children numbers (assuming reliable vaccine supply and no patient costs), and Q4 is a math exercise asking for minimum vaccines needed to achieve 90% vaccination rate.

Clarifying Information

Q3 Clarifying Information (if asked):

  1. A lack of trust in the safety of vaccines and a belief that Lasio threat is exaggerated might contribute to the vaccine hesitancy
  2. Potentially low urbanization rate might suggest low population density and thus lead to accessibility issues
  3. Great patient experience might drive word of mouth
  4. Although not game-changing, some additional benefits might increase attractiveness of vaccination to low-income families

Q4 Clarifying Information (provided):

  1. Current vaccination results: 50% of children are fully vaccinated (received 2 doses), 20% of children received 1 dose, 30% of children didn’t receive any doses
  2. Children of all age groups are subject to vaccination
  3. Due to poor storage conditions and inadequate vaccine demand forecasting, 25% of vaccines go to waste
  4. The children population is 5M in this country
  5. The children population growth rate can be neglected [for the purposes of this calculation]